Brighton Jones LLC’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Buy |
22,601
+283
| +1% | +$3.3K | 0.01% | 775 |
|
|
2025
Q1 | $166K | Sell |
22,318
-1,971
| -8% | -$14.6K | 0.01% | 661 |
|
|
2024
Q4 | $146K | Hold |
24,289
| – | – | ﹤0.01% | 653 |
|
|
2024
Q3 | $124K | Sell |
24,289
-1,000
| -4% | -$5.12K | ﹤0.01% | 557 |
|
|
2024
Q2 | $91.5K | Sell |
25,289
-1,200
| -5% | -$4.34K | ﹤0.01% | 611 |
|
|
2024
Q1 | $85K | Buy |
26,489
+604
| +2% | +$1.94K | ﹤0.01% | 612 |
|
|
2023
Q4 | $127K | Sell |
25,885
-14,895
| -37% | -$73K | 0.01% | 559 |
|
|
2023
Q3 | $222K | Buy |
40,780
+223
| +0.5% | +$1.22K | 0.01% | 476 |
|
|
2023
Q2 | $272K | Buy |
40,557
+543
| +1% | +$3.64K | 0.01% | 427 |
|
|
2023
Q1 | $353K | Buy |
40,014
+14,263
| +55% | +$126K | 0.02% | 348 |
|
|
2022
Q4 | $197K | Sell |
25,751
-8,107
| -24% | -$61.9K | 0.01% | 441 |
|
|
2022
Q3 | $241K | Buy |
33,858
+504
| +2% | +$3.59K | 0.01% | 376 |
|
|
2022
Q2 | $270K | Buy |
33,354
+352
| +1% | +$2.85K | 0.02% | 349 |
|
|
2022
Q1 | $458K | Sell |
33,002
-4,195
| -11% | -$58.2K | 0.02% | 293 |
|
|
2021
Q4 | $1.04M | Sell |
37,197
-7,972
| -18% | -$224K | 0.05% | 170 |
|
|
2021
Q3 | $1.54M | Buy |
45,169
+27
| +0.1% | +$918 | 0.08% | 111 |
|
|
2021
Q2 | $1.85M | Sell |
45,142
-305
| -0.7% | -$12.5K | 0.1% | 98 |
|
|
2021
Q1 | $1.83M | Sell |
45,447
-1,485
| -3% | -$59.8K | 0.11% | 91 |
|
|
2020
Q4 | $2.78M | Hold |
46,932
| – | – | 0.17% | 56 |
|
|
2020
Q3 | $2.28M | Buy |
46,932
+395
| +0.8% | +$19.2K | 0.16% | 57 |
|
|
2020
Q2 | $2.25M | Sell |
46,537
-7,409
| -14% | -$358K | 0.18% | 51 |
|
|
2020
Q1 | $1.5M | Buy |
+53,946
| New | +$1.5M | 0.16% | 69 |
|